OREXIGEN THERAPEUTICS INC's ticker is OREXXXXX and the CUSIP is 686164104. A total of 104 filers reported holding OREXIGEN THERAPEUTICS INC in Q1 2016. The put-call ratio across all filers is 5.73 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $11,000 | -67.6% | 20,000 | 0.0% | 0.00% | -71.4% |
| Q4 2015 | $34,000 | -19.0% | 20,000 | 0.0% | 0.01% | -22.2% |
| Q3 2015 | $42,000 | -57.6% | 20,000 | 0.0% | 0.01% | -52.6% |
| Q2 2015 | $99,000 | -36.9% | 20,000 | 0.0% | 0.02% | -36.7% |
| Q1 2015 | $157,000 | +20.8% | 20,000 | -7.0% | 0.03% | +20.0% |
| Q4 2014 | $130,000 | +35.4% | 21,500 | -4.4% | 0.02% | +31.6% |
| Q3 2014 | $96,000 | -30.9% | 22,500 | 0.0% | 0.02% | -29.6% |
| Q2 2014 | $139,000 | +71.6% | 22,500 | +80.0% | 0.03% | +68.8% |
| Q1 2014 | $81,000 | – | 12,500 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management I, LLC | 1,229,287 | $9,625,000 | 44.28% |
| Foresite Capital Management II, LLC | 4,200,047 | $32,886,000 | 19.48% |
| Scale Management, LLC | 2,884,305 | $22,584,000 | 11.28% |
| Cheyne Capital Management (UK) LLP | 1,484,409 | $11,601,000 | 2.80% |
| Telemetry Investments, L.L.C. | 463,039 | $3,626,000 | 2.00% |
| NEA Management Company, LLC | 3,709,000 | $29,041,000 | 1.31% |
| Rock Springs Capital Management LP | 1,550,000 | $12,137,000 | 1.14% |
| Rhenman & Partners Asset Management AB | 831,800 | $6,513,000 | 1.10% |
| Tamarack Capital Management, LLC | 1,000,000 | $7,830,000 | 1.03% |
| RA Capital Management | 1,186,229 | $9,288,000 | 0.92% |